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Mast cells (MC) play an important role on allergic reactions initiated by the IgE/Antigen-dependent crosslinking 
of the high affinity IgE receptor (FcRI). Also, their participation on inflammatory innate immune responses 
triggered by Toll-like receptors (TLRs) is now well documented. Physiological conditions such as stress exert a 
modulatory effect on allergic reactions since stress mediators activate signaling cascades that either interfere or 
potentiate FcRI-dependent cytokine production. Moreover, the effect of stress mediators on cytokine 
production induced after TLR triggering has started to be addressed in this cell type. In a recent paper, we 
analyzed the effects of stress induced by forced swimming (FS) on the MC-dependent production of Tumor 
Necrosis Factor (TNF) induced by a single intraperitoneal injection of bacterial lipopolysaccharide (LPS) in 
mice. FS provoked an immediate and transient inhibition of LPS-elicited TNF accumulation in peritoneum, 
which lasted around to 30 min. With the aim to identify the mediator of stress responsible for the inhibition, we 
first blocked catecholamine release from adrenal glands (by adrenalectomy) or nerve terminals (with DSP4 
treatment). With these manipulations we observed an important increase on basal i.p. NF levels and enhanced 
LPS-induced TNF release without any effect on stress-induced inhibitory effects. We then pre-treated animals 
with the glucocorticoid receptor antagonist mifepristone and did not observe any change on basal levels or 
stress-induced inhibition of TNF release. Finally, we administered an antagonist of acetylcholine receptors 
(mecamylamine) and observed an increase on basal levels of i.p. TNF values together with an important 
blockage of stress effects. Those results show for the first time that early MC-derived TNF secretion after 
Toll-like receptors is negatively controlled by adrenaline and transiently inhibited by the anti-inflammatory 
cholinergic reflex. Our results adds to the description of stress effects on MC activation and open new avenues in 
the research on the control of chronic inflammatory reactions associated with long term MC-dependent cytokine 
secretion 
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Introduction 
Mast cells (MC) have been largely recognized as the 
initiators of allergic reactions [1]. After the crosslinking of the 
high affinity receptor for IgE (FcRI), this cell type secrete 
numerous pro-inflammatory mediators which are 
concentrated on intracellular granules (such as histamine and 
proteases) or synthesized de novo (such as cytokines and 
araquidonic acid derivatives). In response to IgE/Ag 
complexes, MC secrete preformed mediators by a rapid 
process known as “degranulation”, whereas exocytosis of 
cytokines triggered by other stimuli (such as bacterial 
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products) requires events that lead to slow piecemeal 
degranulation or activation of the constitutive secretory 
pathway [2]. Inflammatory mediators exert their effects on 
surrounding tissues, promoting vascular permeability 
changes, recruitment of leukocytes and pain generation. 
Although an initial deleterious role of MC activation was 
accepted, this concept changed with the discovery that MC 
can orchestrate protective inflammatory reactions against 
bacteria, parasites and tissue damage through the 
low-intensity triggering of the FcRI by monomeric IgE, or 
the activation of Pattern Recognition Receptors (PRR) such 
as NOD, RIG and Toll-like receptors (TLRs) [3]. Also, 
non-regulated, long-term cytokine secretion by MC has been 
associated with distinct chronic-degenerative diseases [1].  
The emerging role of MC as main controllers of the 
intensity of local inflammatory reactions triggered by stimuli 
of innate and adaptive immunity, and also as elements able to 
change the course of inflammation from a protective to 
deleterious outcome has lead to investigate the effect of 
stress on their activation. 
During the stress response biochemical changes are 
induced in certain brain areas, notably in limbic areas, which 
converge at the activation of the hypothalamic-pituitary 
-adrenal axis (HPA)[4]. In those conditions, afferent sensory 
neurons activate sympathetic and parasympathetic pathways 
that trigger the production and release of glucocorticoids, 
corticotropin releasing hormone (CRH), vasopressin, 
substance P, neurotensin, adrenaline and acetylcholine, 
among others. Many of these mediators have direct effects on 
the activation of mast cells, either enhancing or suppressing 
responses to various stimuli activation of innate and adaptive 
immunity. 
In some studies using mice subjected to physical and 
psychological stress, such as forced swimming (FS) or 
exposure to a predator, it has been shown that stress 
attenuates the production of pro-inflammatory cytokines in 
response to bacterial lipopolysaccharide (LPS) [5,6]. On the 
other hand, it has been described that various neuroendocrine 
mediators secreted during the stress response, such as 
corticotropin releasing factor (CRH), substance P and 
neurotensin increase degranulation of MC [7-9]. 
The following sections will describe some of the 
molecules relevant for cytokine secretion in MC stimulated 
through FcRI and TLR4 receptors and the effects of stress 
mediators in cytokine production in this particular cell type.  
Mast cells in adaptive immunity 
MC constitute the main cell type involved in the initiation 
of type I hypersensitivity (allergic) reactions because they 
secrete inflammatory mediators after IgE/antigen (IgE/Ag) 
-dependent crosslinking of the FcεRI receptor. The FcεRI is a 
heterotetramer composed by an α subunit that binds to IgE, 
one β subunit that (in mice) is implicated in the amplification 
of the signal, and two γ subunits which initiate the signaling 
cascade. Both the β and γ subunits possess immunotyrosine 
activation motifs (ITAMs), which are phosphorylated by Src 
family kinases, such as Lyn and Fyn.  
Receptor activation promotes the phosphorylation and 
recruitment of some adapter molecules such as linker of 
activation of T cells (LAT), Grb2-associated binder-like 
protein 2 (Gab2), Src homology 2 master-containing 
leukocyte phosphoprotein of 76 kDa (SLP-76) and others. 
Those adapters, in turn, allow the recruitment and activation 
of effector proteins such as phospholipase C (PLC), 
phosphoinositide 3-kinase (PI3K), and small GTPases. PLC 
hydrolyzes the phosphatidyl inositol 4,5-biphosphate 
(PI4,5-P2) producing inositol triphosphate (IP3) and 
diacylglycerol (DAG). IP3 binds to IPR receptors in the 
endoplasmic reticulum and generates calcium depletion in 
this compartment, while the DAG is responsible for 
activating the classical isoforms of PKC, event required for 
degranulation. Phospholipase A induces the formation of 
arachidonic acid derivatives and small GTPases lead to the 
activation of mitogen-activated protein (MAPK) that 
stimulate some transcription factors to promote de novo 
synthesis of cytokines [10-12] (Figure 1). 
Activation of the FcεRI signaling system is related to type 
I hypersensitivity reactions, such as those involved in asthma 
and atopic dermatitis. In those cases, inflammatory mediators 
secreted by the FcRI signaling system leads to 
bronchoconstriction, increased vascular permeability and 
vasodilation [13, 14].  
Mast cells and innate immunity  
MC express pattern recognition receptors (PRRs) such as 
the Toll-like 4 receptor. TLR4 activation is associated to the 
activation of transcription factors (specially NFB) to induce 
de novo cytokine synthesis and their secretion by the 
constitutive pathways, but also induce release of preformed 
mediators by a mechanism known as piecemeal 
degranulation [13]. The most studied ligand for TLR4 receptor 
in MC is the lipopolysaccharide (LPS) from Gram-negative 
bacteria. 
The intracellular response to LPS in MC is initiated by the 
TLR-4 dependent recruitment of the adapter protein MyD88 
(since the activation of MyD88-independent pathways has 
not been reported in this cell type). After this, the TRAF6 
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ubiquitin ligase leads to TAK1 phosphorylation, and TAK1 
bifurcates the signal transduction system on two main 
branches: one leading to the activation of MAP kinases 
(ERK, p38 and JNK) and the IKK-dependent activation of 
NFB. 
Recent studies from our laboratory indicate that IKK and 
ERK phosphorylation are directly related to the process of 
TNF secretion in mast cells. The IKK inhibitor BAY11-7085 
was able to reduce the secretion of TNF in bone 
marrow-derived mast cells (BMMCs) stimulated with LPS. 
Also, the MEK inhibitor PD98059 prevented TNF secretion 
in response to LPS [16]. A closer analysis has shown that IKK 
activation promotes the phosphorylation of membrane 
SNARE proteins involved in cytokine secretion, such as 
SNAP-23[17], but the specific role of ERK is still unknown 
(Figure 1).  
In vivo, there are several mouse models used to study the 
innate response after stimulation of the TLR-4 receptors in 
MC, among them, the cecal ligation and puncture (CLP) 
model involves tying a section of intestine (caecum) with its 
posterior perforation. This allows resident bacteria to invade 
the entire peritoneal cavity initiating the systemic response to 
sepsis [18]. Other models are used to investigate the response 
mounted only to endotoxin and they consist on the direct 
injection of purified LPS to peritoneal cavity [19, 20]. Using 
those models in WT and MC-deficient (Kit Wv/Wv and Kit 
Wsh/Wsh) mice, it has been shown that resident MCs are 
responsible for the early production of TNF during the first 
two hours after TLR-4 stimulation [19, 21, 22].  
In vitro models of TLR4-dependent activation of MC 
consist in the direct stimulation of BMMCs or MC cell lines 
(such as rat RBL 2H3 cells or human LAD-2 cell line) with 
TLR4 ligands. Using those cellular models and accordingly 
to the well-documented mast cell heterogeneity, it has been 
shown that MC response to LPS depends on cell preparation 
and culture conditions [23-25]. For example, in BMMC, TLR4 
stimulation with LPS (500 ng/ml) induces secretion of TNF 
at short times (1 to 4 hours) [24,16] whereas RBL-2H3 cells it 
takes a long-lasting stimulation (6 to 12 h) with high LPS 
concentrations (1 g/mL) to observe an increase on TNF 
production.  
TLR receptors are activated also after the recognition of 
damage-associated molecular patterns (DAMPs), such as 
heat shock proteins [26], β-defensins, fibronectin, hyaluronic 
Figure 1. Main signaling routes connecting FcRI or TLR4 receptors with cytokine production in MC. Upon 
stimulation of the FcεRI signaling cascade with IgE/Ag complexes, distinct pathways are activated to connect the receptor 
with the production of arachidonic acid (1), secretion of the pre-formed content of granules (2) and de novo synthesis of 
cytokines trough transcription of specific genes and mRNA stabilization (3). After activation of TLR4 receptor, a pathway 
inducing the activation of various transcription factors to produce the synthesis of pro-inflammatory cytokines is turned on 
(3), but selective exocytosis of granule content (such as TNF) is also observed (4).  
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acid, β-amyloid peptide [24], and fatty acids [28]. Recent 
evidence indicates that in chronic-degenerative diseases, 
those agents could be responsible for TLR receptors 
triggering on MC surface. For example, in the case of 
rheumatoid arthritis, local and long-lasting inflammatory 
reactions eventually lead to destruction of cartilage and bone. 
In this process, the damage sinovium produce DAMPs such 
as fibronectin, which activate MC similarly to what occurs 
with LPS. MC, in turn, contribute to the increased 
inflammatory response in the damaged tissue [29]. 
Mediators of stress and its effects on the activation of 
mast cells 
HPA activation induces the production of CRH in the 
paraventircular nuclei of the hypothalamus. This hormone 
travels through the pituitary portal and promotes ACTH 
production in the anterior pituitary. On the other hand, in the 
adrenal cortex promotes the production of glucocorticoids. 
Some of the secreted mediators during activation of the HPA 
axis may per se induce cytokine release from MC but also 
can modify their response to stimulation of TLR and FcRI 
receptors by a mechanism that has not been fully described 
(Figures 2 and 3).  
Corticotropin-releasing hormone (CRH) 
CRH is a peptide synthesized in response to stress in 
paraventricular nucleus of the hypothalamus. However, at the 
periphery, other cell types such as MC are able to synthesize 
it [30]. CRH acts through its G-protein-coupled receptors 
(GPCRs), CRH-R1 and CRH-R2. When activated, their 
signaling cascades increase intracellular concentrations of 
cAMP by action of Adenylyl cyclase (AC), and, eventually, 
activate protein kinase A (PKA) [31]. 
The immobilization stress model has been widely used to 
generate acute stress in rats and mice. This model consists on 
Figure 2. Modulation of FcRI-dependent responses by stress hormones in MC. IgE/Ag-induced degranulation and 
cytokine synthesis is positively affected by neurotensin receptors (NT-R) by a mechanism depending on calcium 
mobilization and activation of specific transcription factors. Those pro-inflammatory signals are negatively controlled by the 
activation of 2-adrenergic (AR-2) receptors and cytoplasmic or membrane glucocorticoid receptors (c and m GCR). 
AR-2 and GCR also interfere with the activation of calcium channels and enzymes responsible for the production of 
lipid-derived inflammatory mediators (see text for details).  
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the introduction of the animal into a cylinder designed 
accordingly to prevent movement of scape of the 
experimental subject. Under those conditions, it has been 
shown that stress induces intracranial and skin degranulation 
of MC in the rat. MC degranulation was not observable when 
animals were pre-treated with and anti-CRH serum prior to 
immobilization [7, 9]. 
The presence of CRH-1 and CRH-2 receptors has been 
reported in a human leukemia mast cell line (HMC-1). 
Activation of these cells with CRH selectively promoted the 
secretion of VEGF, but not tryptase, histamine or certain 
other cytokines. The increased secretion of VEGF was 
associated with the activation of AC and PKA, since VEGF 
secretion was increased with froskolin and inhibited with 
SQ22536 (an inhibitor of AC) or the CRH-1 antagonist 
alarmin [32]. CRH acting on the CRH-R1 induces 
phosphorylation of P-38 MAPK, but not ERK or JNK in MC 
[33]. Similar studies, performed with the human mast cell line 
LAD-2, have found that secretion of CRH enhances VEGF 
production induced after activation of FcεRI [34].  
Glucocorticoids  
Glucocorticoids are the best-studied mediators released 
after stress responses. Their actions on the immune response 
have been extensively characterized and generally lead to the 
suppression of inflammation, reason by which they are wide 
prescribed for the treatment of multiple diseases such as 
asthma and distinct types of allergies.  
Glucocorticoids have anti-inflammatory effect by acting 
on their receptors that, without any stimulus, are localized in 
the cytoplasm (cGCR) forming complexes with chaperone 
proteins such as the 90 kDa heat shock protein (Hsp90). 
After binding of the ligand, the complex dissociates and 
cGCR protein is transported to cell nucleus where it binds to 
hormone response elements on DNA, inducing the 
transcription of genes that interfere with the activation of the 
transcription factor NFκB such as IκB [35-37]. In MC isolated 
from dexamethasone-treated animals or in 
dexamethasone-treated BMMCs [38, 40] a reduction on the 
secretion of preformed mediators such as -hexosaminidase, 
Figure 3. Modulation of TLR4-dependent responses by adrenergic and nicotinic 7 acetylcholine (nAchR7) 
receptors. In murine peritoneal cavity, MC-dependent production of TNF after LPS addition in is negatively controlled by 
adrenaline (secreted by adrenal glands or by peripheral nerve terminals) and by acetylcholine released after swim stress. 
Molecular mechanisms behind this inhibition remain to be described (see text for details).  
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serotonin and certain arachidonic acid derivatives was 
observed [40]. The molecular mechanism behind the blockage 
on the secretion of pre-formed mediators in MC has not been 
fully described but some experiments in RBL-2H3 cells 
indicate that a pre-incubation with corticosterone causes an 
inhibition on the rise on intracellular calcium current [Ca2+]I, 
which is necessary for histamine release [41].  
We have reported that the inhibitory effects of swim stress 
on MC-dependent, LPS-induced TNF secretion in peritoneal 
cavity were not prevented by pretreatment with mifepristone 
(a commonly used antagonist of GR) despite the important 
increase on corticosterone plasma levels observed [6]. Our 
results suggest that GR exerts a marginal control on TNF 
secretion stimulated by TLR4 receptors in MC.  
Finally, membrane glucocorticoid receptors (mGCR) have 
been found in a number of immune cells and their activation 
causes changes in basic properties of plasma membrane, 
affecting intracellular concentrations of Ca2+, ATP and 
cAMP [42, 43]. Also, changes on membrane localization of 
mGCR were detected in RBL-2H3 cells after IgE/antigen 
stimulation [44]. 
Catecholamine  
During the stress response, adrenaline and noradrenaline 
are secreted by chromaffin cells located in the adrenal 
medulla by a process dependent on acetylcholine release. 
Those catecholamines activate with different affinities three 
subtypes of G-protein coupled receptors known as 
adrenoceptors α1, α2 and β (1, 2, 3). β2-adrenergic receptor is 
positively coupled to Gs protein and promotes the activation 
of AC, resulting in the intracellular increase of cAMP levels. 
MC express this receptor subtype and has been widely 
studied because its activation modulates the main 
inflammatory reaction associated to asthma [45, 46]. In an 
study conducted in 2001 by Graveskaya et al [47] peritoneal 
MC purified from rats exposed to cold stress (inmersion of 
animals for 5 min in a water bath at 4°C) were stimulated 
with the calcium ionophore A23187 or the secretagogue 
compound 48/80. Authors found that stress inhibited 
A23187-induced histamine release and same effect was 
observed when, instead of exposing rats to stress, were 
administered with epinephrine. Other in vivo studies have 
reported that treatment with isoproterenol and clembuterol 
(two different β-adrenergic agonists) decreases the skin 
anaphylactic reaction and the IgE/Ag-induced peritoneal 
histamine secretion [48]. On the other hand, studies in MC 
isolated from lung or intestine reported a decrease in the 
secretion of histamine, leukotrienes and prostaglandins when 
cells were pre-incubated with β-adrenergic agonists [46, 48-51].  
Some molecular events have been proposed to explain the 
inhibitory effects that AR-β2 stimulation exerts on the FcεRI 
signaling system. It is known, for example, that an increase 
on cAMP is required for the phenomenon, since incubation 
with forskolin mimics the inhibitory effects of β-adrenergic 
agonists [52]. Also, it has been shown that the adrenergic 
inhibition is prevented when cells are simultaneously 
incubated with cholera toxin, experiment that confirms the 
participation of Gs. It has also been reported that the β2-AR 
agonist salbutamol inhibits calcium currents evoked by 
FcεRI triggering in an event that involves the blockage of 
potassium channels activity (iKCa1) necessary for mast cells 
degranulation [53]. 
Adrenalectomy importantly increased basal and 
LPS-triggered levels of TNF in the peritoneal cavity of mice, 
an effect also observed after pharmacological lesion of the 
noradrenergic system with the specific neurotoxin DSP-4. 
However, any of those manipulations altered the deletereous 
effects of swim stress [6], suggesting that catecholamines 
maintain an inhibitory tone on the peritoneal amount of TNF 
but do not alter the acute effects of stress on that parameter.  
Neurotensin  
Neurotensin (NT) is a peptide secreted at nerve terminals 
in response to tissue injury or pain. Acting on its G-coupled 
receptor (NT-R), this hormone directly activates MC and 
induces the secretion of β-hexosaminidase and histamine and 
enhances the response to IgE/Ag [54, 55]. NT also increases the 
expression of VEGF mRNA and CRH, phenomena related to 
the increase in intracellular Ca2+ and the activation of the 
transcription factor NFκB [9]. Elevated levels of NT have 
been found in serum of patients of psoriasis, phenomenon 
that may explain why some psoriasis patients worsening 
when subjected to stress [56]. In addition, it has been reported 
that acute restraint stress increases cardiac degranulation 
mast cells and that the effect is blocked when the animals are 
pre-administered with an antagonist to NT-R [57, 58]. This 
phenomenon could be relevant in the development of chronic 
cardiovascular diseases. 
Acetylcholine 
During the stress response, cholinergic pathways 
innervating diverse regions of the limbic system are activated 
[59-61]. Acetylcholine causes the release of catecholamines in 
the adrenal medulla and acts directly on their muscarinic and 
nicotinic receptors located on the plasma membrane of many 
cells of the immune system, thereby modulating 
inflammatory responses. The mechanisms by which 
acetylcholine modulates inflammation have been widely 
described over the past decades generating the discovery of 
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an inhibitory pathway known as the cholinergic 
anti-inflammatory reflex. Cholinergic anti-inflammatory 
reflex is composed by a set of interactions that take place 
between the immune cells and nerve terminals. When 
inflammation starts in certain location, cytokines and 
mediators secreted by immune cells activate its specific 
receptors on vagal afferent nerve terminals. This signal is 
integrated into the CNS, in the nucleus of the solitary tract 
and the hypothalamus, causing that the efferent vagal 
terminals of the celiac ganglion secrete acetylcholine that 
promotes secretion of catecholamines. Released 
catecholamines act on -adrenergic receptors in resident T 
cells in the spleen. These cells produce and release 
acetylcholine that inhibits the production of 
pro-inflammatory cytokines to activate the receptors 
nAchRα7 on adjacent spleen macrophages [62]. 
The inhibitory downstream events triggered by the 
activation of nAchRα7 receptors have been described 
primarily in macrophages, however, some studies have also 
been made in other cell types such as mast cells and 
microglia [63, 65]. In general, it is known that nAchRα7 
activation induces recruitment of molecules such JAK and 
STAT, which inhibit the activity of the transcription factor 
NFκB [66]. In rodent models of endotoxemia it has been seen 
that electrical stimulation of the vagus nerve attenuates 
proinflammatory cytokine concentrations in serum and also 
prevents the development of endotoxic shock [67]. 
The anti-inflammatory effects of acetylcholine have been 
demonstrated in other in vivo models of inflammation. In our 
study, we observed that the inhibitory effect evoked by stress 
can be prevented by treating mice with the nicotinic 
antagonist mecamylamine [6]. These results suggest that 
acetylcholine released in response to stress activate nicotinic 
receptors on MC and inhibit MC responses to LPS. In vitro 
studies have demonstrated the presence of nicotinic receptors 
in BMMCs [68-69]. In RBL-2H3 cells, the effect of nicotinic 
agonists such as nicotine and GTS-21 has been evaluated and 
results indicate that the nicotinic agonist can inhibit the 
production of leukotrienes, β-hexosaminidase and histamine 
induced by FcεRI activation [70]. Despite the importance that 
PAMP and DAMP-induced cytokine synthesis by MC has on 
the development of chronic inflammatory conditions, the 
molecular mechanisms of inhibition mediated by stress are 
still far from being described (Figure 3).   
Conclusions 
Stress mediators induce important modifications to MC 
responses to stimuli from the innate and the adaptive immune 
system. Some of those mediators show a positive effect on 
the response triggered by the FcRI, such as CRH and 
substance P, while other exert negative effects, such as 
glucocorticoids, catecholamines and acetylcholine. In 
contrast, the existing information about the effects of stress 
mediators on MC-dependent cytokine synthesis after 
stimulation of TLR receptors is scarce. Our recent findings 
reporting the transient inhibitory role of stress on the 
TLR4-dependent cytokine production in MC through the 
activation of the anti-inflammatory reflex open new avenues 
in the identification of therapeutic targets for chronic- 
degenerative diseases in which long-term production of 
cytokines associated to MC activation is related with 
progressive tissue damage.  
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